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Background
Small studies with composite endpoints show that mid-
wall fibrosis, identified by late gadolinium enhancement
cardiovascular magnetic resonance (LGE-CMR), predicts
short term adverse prognosis in dilated cardiomyopathy
(DCM). We hypothesized that midwall fibrosis is an
independent predictor of mortality over a long follow-
up period.
Methods
Consecutive patients with DCM referred for CMR
between 2002-2008 were prospectively enrolled. The
diagnosis of DCM was made using clinical, CMR and
coronary angiographic findings. Patients with ischemic
heart disease, primary valvar disease and infiltrative CM
were excluded. LGE-CMR at 1.5T (Siemens Sonata or
Avanto, Germany) was performed in 2 phase-encoding
directions. The presence of midwall LGE was deter-
mined by a specialist blinded to all outcome data. The
primary endpoint was all-cause mortality. The secondary
endpoint was a composite of cardiovascular (CV) mor-
tality or cardiac transplantation.
Results
Two hundred and thirty patients (157 male, mean age
50 yrs, mean LVEF 35%) were followed up for a median
duration of 44 months. Midwall fibrosis was identified
in 87 (38%) patients. No patient was lost to follow-up.
There were 33 deaths (26 CV deaths, 7 non-cardiac)
and 7 patients underwent cardiac transplantation.
Kaplan-Meier analysis demonstrated a significant asso-
ciation between the presence of midwall fibrosis and
both the primary (p=0.02, Fig.1) and secondary
(p=0.003) endpoints. Midwall fibrosis remained a
significant independent predictor of all-cause mortality
(HR 2.2, 95% CI 1.1 to 4.7; p=0.035) and CV mortality/
transplantation (HR 2.8, 95% CI 1.3 to 6.0; p=0.007) on
stepwise Cox regression multivariable analysis allowing
for conventional outcome predictors.
Conclusions
Midwall fibrosis is a significant independent predictor of
both all-cause mortality and CV mortality/transplanta-
tion in DCM. Detection of midwall fibrosis by LGE-
CMR represents an important and novel marker for the
risk stratification of DCM patients.
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Figure 1 Kaplan-Meier survival estimates for all-cause mortality.
Patients are grouped by presence (LGE+) or absence (LGE-) of
midwall LGE.
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